AIM
Arcadia Investment Management Portfolio holdings
AUM
$625M
1-Year Return
22.79%
This Quarter Return
+5.67%
1 Year Return
+22.79%
3 Year Return
+103.01%
5 Year Return
+165.12%
10 Year Return
+401.12%
AUM
$585M
AUM Growth
+$20M
(+3.5%)
Cap. Flow
-$1.53M
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
40.16%
Holding
332
New
20
Increased
57
Reduced
82
Closed
26
Top Buys
| 1 |
Veeva Systems
VEEV
|
+$2.36M |
| 2 |
Eli Lilly
LLY
|
+$1.53M |
| 3 |
Idexx Laboratories
IDXX
|
+$973K |
| 4 |
Amazon
AMZN
|
+$959K |
| 5 |
ProShares Short S&P500
SH
|
+$956K |
Top Sells
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$1.68M |
| 2 |
Air Products & Chemicals
APD
|
+$1.54M |
| 3 |
Intuit
INTU
|
+$1.29M |
| 4 |
Illinois Tool Works
ITW
|
+$1.17M |
| 5 |
Zoetis
ZTS
|
+$888K |
Sector Composition
| 1 | Technology | 39.19% |
| 2 | Healthcare | 12.98% |
| 3 | Consumer Discretionary | 9.54% |
| 4 | Industrials | 8.17% |
| 5 | Consumer Staples | 6.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
York Water
YORW
$442M
| $29.7K | 0.01% |
800
| – | – |
|
227
Credo Technology Group
CRDO
$25.8B
| $28.8K | ﹤0.01% |
+903
| New | +$28.8K |
|
228
Dutch Bros
BROS
$8.33B
| $27.3K | ﹤0.01% |
+659
| New | +$27.3K |
|
229
Gentex
GNTX
$6.19B
| $27K | ﹤0.01% |
800
| – | – |
|
230
Progyny
PGNY
$1.98B
| $25.7K | ﹤0.01% |
898
| – | – |
|
231
Loar Holdings
LOAR
$7.35B
| $25.6K | ﹤0.01% |
+480
| New | +$25.6K |
|
232
MYR Group
MYRG
$2.71B
| $24.6K | ﹤0.01% |
181
+18
| +11% | +$2.44K |
|
233
CAVA Group
CAVA
$7.57B
| $23.3K | ﹤0.01% |
251
-58
| -19% | -$5.38K |
|
234
Sterling Infrastructure
STRL
$8.72B
| $23.2K | ﹤0.01% |
+196
| New | +$23.2K |
|
235
Procept Biorobotics
PRCT
$2.2B
| $22.4K | ﹤0.01% |
+366
| New | +$22.4K |
|
236
Lattice Semiconductor
LSCC
$9.05B
| $22.2K | ﹤0.01% |
383
-306
| -44% | -$17.7K |
|
237
Clearwater Analytics
CWAN
$5.93B
| $22K | ﹤0.01% |
1,188
+211
| +22% | +$3.91K |
|
238
LGI Homes
LGIH
$1.45B
| $21.7K | ﹤0.01% |
242
-378
| -61% | -$33.8K |
|
239
Smith Douglas Homes
SDHC
$1.01B
| $19.9K | ﹤0.01% |
+852
| New | +$19.9K |
|
240
Dollar General
DG
$23B
| $19.8K | ﹤0.01% |
150
| – | – |
|
241
Vericel Corp
VCEL
$1.64B
| $18.9K | ﹤0.01% |
411
-104
| -20% | -$4.77K |
|
242
Ares Capital
ARCC
$15.7B
| $18.8K | ﹤0.01% |
900
| – | – |
|
243
FIVE9
FIVN
$2.04B
| $18.4K | ﹤0.01% |
418
-34
| -8% | -$1.5K |
|
244
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$851M
| $18.4K | ﹤0.01% |
410
| – | – |
|
245
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.6B
| $18.2K | ﹤0.01% |
189
| – | – |
|
246
AstraZeneca
AZN
$252B
| $17.3K | ﹤0.01% |
222
| – | – |
|
247
Comerica
CMA
$8.88B
| $16.8K | ﹤0.01% |
330
+215
| +187% | +$11K |
|
248
SPDR Gold Trust
GLD
$115B
| $16.8K | ﹤0.01% |
78
| – | – |
|
249
Voyager Therapeutics
VYGR
$222M
| $15.8K | ﹤0.01% |
+2,000
| New | +$15.8K |
|
250
QuinStreet
QNST
$933M
| $15.7K | ﹤0.01% |
948
| – | – |
|